Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Carvana
CVNA
|
+$854M |
| 2 |
Microsoft
MSFT
|
+$754M |
| 3 |
Apple
AAPL
|
+$503M |
| 4 |
Amazon
AMZN
|
+$465M |
| 5 |
PayPal
PYPL
|
+$392M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$824M |
| 2 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$607M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$500M |
| 4 |
Boston Scientific
BSX
|
+$214M |
| 5 |
Fidelity High Dividend ETF
FDVV
|
+$211M |
Sector Composition
| 1 | Technology | 22.53% |
| 2 | Financials | 10.32% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Healthcare | 8.49% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Krystal Biotech
KRYS
$4.16B
| $2.44M | ﹤0.01% |
34,888
+4,926
| +16% | +$345K |
|
|
CHCT
1802
Community Healthcare Trust
CHCT
$445M
| $2.44M | ﹤0.01% |
51,580
+1,743
| +3% | +$82.4K |
|
|
WPCB.U
1803
DELISTED
Warburg Pincus Capital Corporation I-B Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCB.U
| $2.44M | ﹤0.01% |
245,000
| – | – |
|
|
CSR
1804
Centerspace
CSR
$979M
| $2.44M | ﹤0.01% |
21,959
+3,258
| +17% | +$361K |
|
1805
Kura Oncology
KURA
$711M
| $2.44M | ﹤0.01% |
173,934
+20,551
| +13% | +$288K |
|
1806
Webster Financial
WBS
$10.2B
| $2.43M | ﹤0.01% |
43,599
-87,460
| -67% | -$4.88M |
|
1807
ABM Industries
ABM
$2.8B
| $2.43M | ﹤0.01% |
59,555
+15,757
| +36% | +$644K |
|
1808
MACOM Technology Solutions
MTSI
$9.82B
| $2.43M | ﹤0.01% |
31,049
+8,222
| +36% | +$644K |
|
1809
iShares Expanded Tech Sector ETF
IGM
$8.98B
| $2.43M | ﹤0.01% |
33,198
-2,580
| -7% | -$189K |
|
1810
Vanguard Industrials ETF
VIS
$6.13B
| $2.42M | ﹤0.01% |
11,931
-98,576
| -89% | -$20M |
|
1811
EnerSys
ENS
$4B
| $2.42M | ﹤0.01% |
30,596
+8,370
| +38% | +$662K |
|
1812
WEX
WEX
$5.82B
| $2.42M | ﹤0.01% |
17,216
+364
| +2% | +$51.1K |
|
1813
Selective Insurance
SIGI
$4.81B
| $2.42M | ﹤0.01% |
29,473
+355
| +1% | +$29.1K |
|
1814
Quaker Houghton
KWR
$2.46B
| $2.4M | ﹤0.01% |
10,381
+3,197
| +45% | +$738K |
|
1815
Shutterstock
SSTK
$742M
| $2.39M | ﹤0.01% |
21,594
-422
| -2% | -$46.8K |
|
1816
Ziff Davis
ZD
$1.5B
| $2.39M | ﹤0.01% |
21,596
+3,994
| +23% | +$443K |
|
1817
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$41.9B
| $2.39M | ﹤0.01% |
26,144
-7,501
| -22% | -$686K |
|
1818
First Bancorp
FBP
$3.49B
| $2.39M | ﹤0.01% |
173,257
+41,524
| +32% | +$572K |
|
1819
Vanda Pharmaceuticals
VNDA
$266M
| $2.38M | ﹤0.01% |
151,874
+58,518
| +63% | +$918K |
|
1820
Herc Holdings
HRI
$4.2B
| $2.38M | ﹤0.01% |
15,207
+7,673
| +102% | +$1.2M |
|
1821
Piper Sandler
PIPR
$6.12B
| $2.38M | ﹤0.01% |
13,312
+3,802
| +40% | +$679K |
|
1822
AptarGroup
ATR
$8.91B
| $2.38M | ﹤0.01% |
19,389
-3,889
| -17% | -$476K |
|
1823
Invesco NASDAQ Biotechnology ETF
IBBQ
$36.5M
| $2.37M | ﹤0.01% |
100,000
-300,000
| -75% | -$7.12M |
|
1824
Axcelis
ACLS
$2.69B
| $2.37M | ﹤0.01% |
31,818
+9,519
| +43% | +$710K |
|
1825
Medifast
MED
$154M
| $2.37M | ﹤0.01% |
11,324
+2,109
| +23% | +$442K |
|